Guidelines for the treatment of ulcerative colitis in remission

Guidelines for the treatment of ulcerative colitis in remission The role is reviewed of sulphasalazine, 5‐aminosalicylic acid (5‐ASA), immunosup‐pressive agents and corticosteroids in the maintenance treatment of ulcerative colitis in remission. Sulphasalazine and oral 5‐ASA are the drugs of first choice in preventing relapses for patients suffering from intermittent chronic ulcerative colitis. Rectally administered 5‐ASA may be a valid alternative for treating patients with proctitis and left‐sided ulcerative colitis. The optimal dosage of oral 5‐ASA in the maintenance therapy of ulcerative colitis in remission is not clear. However, there is evidence that a higher dose of 5‐ASA is more effective than low dosage in preventing relapses in patients in remission. For patients with chronically active or steroid‐dependent ulcerative colitis who have achieved remission while taking immunosup‐pressants, continuing azathioprine or 6‐mercaptopurine is indicated. Existing data cast doubts as to whether or not continuous maintenance is still necessary in patients suffering from intermittent chronic ulcerative colitis with prolonged endoscopic, clinical and histological remission. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Gastroenterology & Hepatology Wolters Kluwer Health

Guidelines for the treatment of ulcerative colitis in remission

Loading next page...
 
/lp/wolters_kluwer/guidelines-for-the-treatment-of-ulcerative-colitis-in-remission-A3me7COELC
Copyright
© Rapid Science Publishers ISSN 0954‐691X
ISSN
0954-691X
eISSN
1473-5687

Abstract

The role is reviewed of sulphasalazine, 5‐aminosalicylic acid (5‐ASA), immunosup‐pressive agents and corticosteroids in the maintenance treatment of ulcerative colitis in remission. Sulphasalazine and oral 5‐ASA are the drugs of first choice in preventing relapses for patients suffering from intermittent chronic ulcerative colitis. Rectally administered 5‐ASA may be a valid alternative for treating patients with proctitis and left‐sided ulcerative colitis. The optimal dosage of oral 5‐ASA in the maintenance therapy of ulcerative colitis in remission is not clear. However, there is evidence that a higher dose of 5‐ASA is more effective than low dosage in preventing relapses in patients in remission. For patients with chronically active or steroid‐dependent ulcerative colitis who have achieved remission while taking immunosup‐pressants, continuing azathioprine or 6‐mercaptopurine is indicated. Existing data cast doubts as to whether or not continuous maintenance is still necessary in patients suffering from intermittent chronic ulcerative colitis with prolonged endoscopic, clinical and histological remission.

Journal

European Journal of Gastroenterology & HepatologyWolters Kluwer Health

Published: Sep 1, 1997

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off